Back
EHRA Premium Access

Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation

Session: Ventricular Arrhythmias and SCD - Round 3 - Ablation
Topic: Ablation of Ventricular Arrhythmias
Speaker: Doctor J. Al-Sheikhli (Coventry, GB)
Event: EHRA 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jaffar Al-Sheikhli

University Hospitals of Coventry and Warwickshire NHS Trust, Coventry (United Kingdom of Great Britain & Northern Ireland)
0 follower

8 more presentations in this session

Reproducible target transfer from electroanatomic mapping to radiotherapy planning systems for cardiac radioablation - cross-validation for the RAVENTA trial

Speaker: Doctor S. Hohmann (Hannover, DE)

Access
Abstract
Slides
Like
Thumbnail

Stereotactic Arrhythmia Radioablation (STAR) for refractory ventricular tachycardia (VT) - A preliminary report from the German multicenter RAVENTA study

Speaker: Doctor S. Hohmann (Hannover, DE)

Access
Abstract
Slides
Like
Thumbnail

Impact of cardiac magnetic resonance channels to localize deceleration zones during VT ablation

Speaker: Doctor S. Vazquez-Calvo (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Sex differences in catheter ablation for ventricular tachycardia in structural heart disease: a single center 10-years experience.

Speaker: Doctor N. Tanese (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Impact of ventricular tachycardia ablation in S-ICD recipients: insights from the multicenter iSUSI registry

Speaker: Doctor M. Schiavone (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Ventricular Arrhythmias and SCD - Round 3 - Ablation

Speakers: Doctor J. Al-Sheikhli, Doctor S. Hohmann, Doctor S. Hohmann, Doctor S. Vazquez-Calvo, Doctor N. Tanese...
Access
Like
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources